Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary function tests in connective tissue disease.

Athol U Wells1

  • 1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom. a.wells@rbh.nthames.nhs.uk

Seminars in Respiratory and Critical Care Medicine
|September 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive pulmonary fibrosis: a state-of-the-art review.

The European respiratory journal·2026
Same author

Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung disease.

ERJ open research·2026
Same author

Changes in Interstitial Lung Disease Nomenclature.

Archivos de bronconeumologia·2026
Same author

Response.

Chest·2026
Same author

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease.

American journal of respiratory and critical care medicine·2026
Same author

An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis.

Cell reports. Medicine·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Interpreting pulmonary function tests (PFTs) for connective tissue disease patients is challenging. PFTs are vital for diagnosing lung conditions, assessing severity, and guiding prognosis, especially when multiple complications coexist.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Clinical Medicine

Background:

  • Connective tissue diseases (CTDs) frequently involve the lungs, complicating respiratory assessments.
  • Pulmonary function tests (PFTs) are crucial for evaluating respiratory symptoms in CTD patients.
  • Recognizing distinct PFT profiles for various lung complications in CTDs is essential.

Purpose of the Study:

  • To explore the complexities of interpreting PFTs in patients with connective tissue diseases.
  • To highlight the role of PFTs in diagnosing and staging lung disease in CTDs.
  • To discuss the utility of PFTs in routine monitoring and the challenges posed by coexisting pulmonary conditions.

Main Methods:

  • Review of established pulmonary function test profiles for common CTD-related lung diseases.

Related Experiment Videos

  • Analysis of PFT sensitivity in detecting interstitial lung disease and pulmonary vascular disease.
  • Consideration of maximal exercise testing's role in selected cases.

    • Main Results:

    • PFTs are sensitive for detecting interstitial and pulmonary vascular diseases in CTDs.
    • Characteristic PFT profiles exist for pulmonary fibrosis, vascular disease, restriction, and airway disease.
    • Interpreting PFTs becomes most difficult when multiple pulmonary complications are present simultaneously.

    Conclusions:

    • PFTs are indispensable for diagnosing, staging, and monitoring lung involvement in CTDs.
    • Understanding individual PFT profiles and their interactions is key to accurate interpretation.
    • Maximal exercise testing can help determine the clinical significance of limited findings.